Article Details
Retrieved on: 2022-11-04 08:12:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi ...
Article found on: shareprices.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here